Skip to content
Recall Observatory FDA recall evidence

Drug product

Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bottles (NDC 70518-1977-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

D-0498-2023

March 20, 2023

Class II

Product summary

Firm
RemedyRepack Inc.
Event
Event 91980
Status
Terminated
Classification
Class II
Quantity
3,426 bottles
Official record key
drug-enforcement:D-0498-2023

Official wording

Reason: cGMP Deviations

Code information: Lot #: a) J0659819-110922, Exp. Date 11/30/2023; J0649932-093022, J0649917-093022 Exp. Date 10/31/2023, B2010060-121222, Exp. Date 03/31/24 Lot #: b) B1708575-060122, Exp. Date 05/31/2023; B1879236-092922, Exp. Date 12/31/2023

Distribution pattern: RemedyRepack distributed product to consignees nationwide within the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations